Gender differences in p53 mutational status in small cell lung cancer

被引:0
|
作者
Tseng, JE
Rodriguez, L
Ro, J
Liu, D
Hong, WK
Mao, L
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Mol Biol Lab, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mutations in the p53 tumor suppressor gene have been demonstrated to be one of the most frequent genetic abnormalities in human cancers. Previous studies have shown that the frequency of p53 mutations is significantly higher in small cell lung cancer than in non-small cell lung cancer, However, this conclusion was based in large part on data derived from tumor cell lines and from studies with relatively small sample sizes and biased gender populations. To determine the mutational frequency in the p53 tumor suppressor gene and a potential difference in gender, we analyzed primary small cell lung cancer tumors from 65 patients (37 males and 28 females) for p53 mutations between exons 5 and 9. Mutations were found in 37 of 65 tumors (57%) within the region of p53 analyzed, Interestingly, none of the tumors from females contained more than one mutation, whereas four of the tumors from males contained more than one mutation. The most common mutation in this population was an adenosine-to-guanine transition (27%), followed by guanine-to-thymidine transversion (17%) and guanine-to-adenosine transition (12%). The gender difference in p53 mutational rate identified in this study suggests that a higher proportion of female tumors may develop through pathways not involving p53 mutations.
引用
收藏
页码:5666 / 5670
页数:5
相关论文
共 50 条
  • [21] p53 Gene status in relation to ex vivo chemosensitivity of non-small cell lung cancer
    U. Vogt
    A. Zaczek
    F. Klinke
    A. Granetzny
    K. Bielawski
    B. Falkiewicz
    Journal of Cancer Research and Clinical Oncology, 2002, 128 : 141 - 147
  • [22] P53 as a prognostic indicator in non-small cell lung cancer
    Tsobanidou, Ch.
    Papageorgiou, A.
    Anestakis, D.
    Paraskevopoulos, P.
    Angel, J.
    Toliou, Th.
    LUNG CANCER, 2006, 52 : S39 - S39
  • [23] Folate intake and risk of colon cancer in relation to p53 mutational status
    Schernhammer, E.
    Ogino, S.
    Fuchs, C.
    EJC SUPPLEMENTS, 2008, 6 (03): : 49 - 49
  • [24] p53 and lung cancer
    Brambilla, E
    Brambilla, C
    PATHOLOGIE BIOLOGIE, 1997, 45 (10): : 852 - 863
  • [25] Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancer
    Hsu, Robert
    Chen, Denaly
    Xia, Bing
    Feldman, Rebecca
    Cozen, Wendy
    Raez, Luis E.
    Borghaei, Hossein
    Kim, Chul
    Nagasaka, Misako
    Mamdani, Hirva
    Vanderwalde, Ari M.
    Lopes, Gilberto
    Socinski, Mark A.
    Wozniak, Antoinette J.
    Spira, Alexander I.
    Liu, Stephen V.
    Nieva, Jorge J.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [26] Prognostic significance of p53 status in non-small cell lung cancer in correlation with postoperative adjuvant therapy
    Hanaoka, N
    Tanaka, F
    Wada, H
    THORACIC AND CARDIOVASCULAR SURGEON, 2002, 50 (06): : 355 - 359
  • [27] Apoptosis and p53 status predict the efficacy of postoperative administration of UFT in non-small cell lung cancer
    Tanaka, F
    Otake, Y
    Yanagihara, K
    Yamada, T
    Miyahara, R
    Kawano, Y
    Li, M
    Inui, K
    Wada, H
    BRITISH JOURNAL OF CANCER, 2001, 84 (02) : 263 - 269
  • [28] Apoptosis and p53 status predict the efficacy of postoperative administration of UFT in non-small cell lung cancer
    F Tanaka
    Y Otake
    K Yanagihara
    T Yamada
    R Miyahara
    Y Kawano
    M Li
    K Inui
    H Wada
    British Journal of Cancer, 2001, 84 : 263 - 269
  • [29] p53 gene status and modulation of response to cisplatin chemotherapy in non-small cell lung cancer cells
    Barr, M. P.
    Batina, M. B.
    Cuffe, S.
    Finn, S.
    O'Byrne, K. J.
    LUNG CANCER, 2014, 83 : S1 - S1
  • [30] The expression of GST isoenzymes and p53 in non-small cell lung cancer
    Oguztuzun, Serpil
    Aydin, Mehtap
    Demirag, Funda
    Yazici, Ulku
    Ozhavzali, Muzeyyen
    Kilic, Murat
    Iscan, Mesude
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2010, 48 (01) : 122 - 127